Clinical outcomes of patients with chronic pulmonary aspergillosis managed surgically
- 1 November 2020
- journal article
- conference paper
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 58 (5), 997-1003
- https://doi.org/10.1093/ejcts/ezaa137
Abstract
OBJECTIVES: Surgical resection is one treatment modality for chronic pulmonary aspergillosis (CPA), and sometimes a preoperative presumption of lung cancer turns out to be CPA. We have audited our surgical experience with regard to risk factors for relapse, and the value of postoperative monitoring of Aspergillus-immunogolubulin G (IgG) titres. METHODS: All patients with CPA surgically treated at National Aspergillosis Centre (NAC), Manchester, UK (2007-2018), were retrospectively evaluated. Surgical procedures, underlying disorders, Aspergillus-IgG titres (ImmunoCap) and antifungal therapy were evaluated for symptom control, operative complications, CPA relapse and mortality. RESULTS: A total of 61 patients with CPA (28 males, 33 females) were operated on primarily for antifungal therapy failure (51%, n = 31) and presumed lung malignancies (38%, n = 23). Procedures included lobectomy (64%, n = 39), wedge resection (28%, n = 17), segmentectomy (n = 3), pneumonectomy (n = 3) and decortication (n = 2). Overall, 25 (41%) patients relapsed, 26 months (standard deviation: 24.8 months) after surgery. Antifungal therapy before surgery (P = 0.002) or both before and after surgery (P = 0.005) were protective for relapse. The relapse rate within 3 years after surgery (33%, n = 20) was higher than the 3-10 years after surgery (8%, n = 5). At the end of follow-up, the median Aspergillus-IgG titre was lower than at relapse in 12 patients (67 vs 126 mg/l) (P = 0.016). CONCLUSIONS: Surgery in these selected patients with CPA resulted in favourable outcomes. Relapse is common after surgical treatment of CPA but can be minimized with antifungal therapy, emphasizing the importance of an accurate diagnosis prior to surgery.Funding Information
- Lembaga Pengelola Dana Pendidikan
- Indonesia Endowment Fund for Education (20160222045506)
- NIHR
- Manchester Biomedical Research Centre
This publication has 27 references indexed in Scilit:
- Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experienceJournal of Cardiothoracic Surgery, 2013
- Hidden Killers: Human Fungal InfectionsScience Translational Medicine, 2012
- Pulmonary Aspergillosis: Therapeutic Management and Prognostic Factors from 16 Years of Monocenter ExperienceAdvances in Experimental Medicine and Biology, 2012
- Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosisBulletin of the World Health Organization, 2011
- Underlying conditions in chronic pulmonary aspergillosis including simple aspergillomaEuropean Respiratory Journal, 2010
- Surgery for Pulmonary Aspergilloma in Immunocompetent Patients: No Benefit From Adjuvant Antifungal PharmacotherapyThe Annals of Thoracic Surgery, 2010
- Surgical outcome of pulmonary aspergillomaEuropean Journal of Cardio-Thoracic Surgery, 2008
- Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplastyEuropean Journal of Cardio-Thoracic Surgery, 2005
- Good Long-Term Outcomes After Surgical Treatment of Simple and Complex Pulmonary AspergillomaThe Annals of Thoracic Surgery, 2005
- Clinical Evaluation of 61 Patients with Pulmonary Aspergilloma.Internal Medicine, 2000